A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic Function

Clinical trial NCT07540754 · RECRUITING

Trial details

NCT number: NCT07540754
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus Weight Loss

Start date: 2026-05-26
Primary completion: 2027-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.